Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis

Nanchang Xie1, Hui Li, Dailin Wei

  • 1Department of Neurology, Qilu Hospital, Shandong University, Jinan 250012, China.

Neuropharmacology
|July 6, 2010
PubMed

Insights

Morphine triggers microglia cell death via opioid receptors. This process involves the glycogen synthase kinase-3 beta (GSK-3β) and p38 mitogen-activated protein kinase (MAPK) pathways, leading to apoptosis.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Opioids are potent analgesics with known adverse effects beyond addiction.
  • Previous research indicated opioids inhibit lymphocyte growth and induce apoptosis.
  • The mechanism of opioid-induced microglia apoptosis remained unclear.

Purpose of the Study:

  • To elucidate the mechanism underlying morphine-induced apoptosis in microglial cells.
  • To investigate the role of opioid receptors, Akt, GSK-3β, and p38 MAPK in this process.

Main Methods:

  • Morphine treatment of BV-2 and primary mouse microglial cells.
  • Assessment of apoptosis and caspase-3 activation.
  • Analysis of phosphorylated Akt (p-Akt) and p-GSK-3β levels.
  • Pharmacological inhibition of GSK-3β and p38 MAPK.

Main Results:

  • Morphine induced microglia apoptosis and caspase-3 activation in an opioid-receptor dependent manner.
  • Morphine decreased p-Akt and p-GSK-3β levels.
  • GSK-3β inhibition potentiated morphine-induced apoptosis and increased phospho-p38 MAPK.
  • p38 MAPK inhibition significantly reduced morphine-induced apoptosis and caspase-3 activation.

Conclusions:

  • Morphine induces microglial apoptosis through opioid receptors.
  • The GSK-3β and p38 MAPK pathways are critical mediators of this effect.
  • These findings reveal a novel mechanism of opioid neurotoxicity in microglia.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...